(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MTHFD2 mRNA] CTD PMID:31150632 1,1-dichloroethene increases expression ISO RGD:1322702 6480464 vinylidene chloride results in increased expression of MTHFD2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:1322702 6480464 1, 2-Dimethylhydrazine results in increased expression of MTHFD2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1322702 6480464 Ethinyl Estradiol affects the expression of MTHFD2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1322702 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MTHFD2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1322702 6480464 Ethinyl Estradiol results in increased expression of MTHFD2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1322701 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MTHFD2 mRNA CTD PMID:20823114 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of MTHFD2 mRNA CTD PMID:26496021 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1322702 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1322701 6480464 Tetrachlorodibenzodioxin results in decreased expression of MTHFD2 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MTHFD2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MTHFD2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MTHFD2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1322701 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of MTHFD2 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1322702 6480464 Tetrachlorodibenzodioxin results in increased expression of MTHFD2 mRNA CTD PMID:21496263 , PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1322702 6480464 Tetrachlorodibenzodioxin affects the expression of MTHFD2 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1322702 6480464 Tetrachlorodibenzodioxin results in decreased expression of MTHFD2 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1322702 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MTHFD2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1322701 6480464 Tetrachlorodibenzodioxin results in increased expression of MTHFD2 mRNA CTD PMID:21496263 2-butoxyethanol increases expression ISO RGD:1322702 6480464 n-butoxyethanol results in increased expression of MTHFD2 mRNA CTD PMID:19812364 2-methylcholine affects expression ISO RGD:1322701 6480464 beta-methylcholine affects the expression of MTHFD2 mRNA CTD PMID:21179406 3-methylcholanthrene multiple interactions ISO RGD:1322702 6480464 [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of MTHFD2 mRNA CTD PMID:25926378 4-hydroxyphenyl retinamide increases expression ISO RGD:1322702 6480464 Fenretinide results in increased expression of MTHFD2 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO RGD:1322702 6480464 Fenretinide results in decreased expression of MTHFD2 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide affects expression ISO RGD:1322701 6480464 Fenretinide affects the expression of MTHFD2 mRNA CTD PMID:16570282 5-azacytidine decreases expression ISO RGD:1322701 6480464 Azacitidine results in decreased expression of MTHFD2 mRNA CTD PMID:20823114 acetamide increases expression EXP 6480464 acetamide results in increased expression of MTHFD2 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of MTHFD2 mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:1322701 6480464 Acrylamide results in increased expression of MTHFD2 mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of MTHFD2 mRNA CTD PMID:23630614 , PMID:25378103 aflatoxin B1 decreases expression ISO RGD:1322702 6480464 Aflatoxin B1 results in decreased expression of MTHFD2 mRNA CTD PMID:19770486 aflatoxin B1 affects expression ISO RGD:1322701 6480464 Aflatoxin B1 affects the expression of MTHFD2 protein CTD PMID:20106945 all-trans-retinoic acid decreases expression ISO RGD:1322701 6480464 Tretinoin results in decreased expression of MTHFD2 mRNA CTD PMID:23724009 , PMID:33167477 antimycin A increases expression ISO RGD:1322701 6480464 Antimycin A results in increased expression of MTHFD2 mRNA CTD PMID:33512557 antirheumatic drug decreases expression ISO RGD:1322701 6480464 Antirheumatic Agents results in decreased expression of MTHFD2 mRNA CTD PMID:24449571 arsenous acid increases expression ISO RGD:1322701 6480464 Arsenic Trioxide results in increased expression of MTHFD2 mRNA CTD PMID:24356939 artesunate decreases response to substance ISO RGD:1322701 6480464 MTHFD2 mRNA results in decreased susceptibility to artesunate CTD PMID:20144594 atrazine decreases expression ISO RGD:1322701 6480464 Atrazine results in decreased expression of MTHFD2 mRNA CTD PMID:22378314 Azaspiracid increases expression ISO RGD:1322701 6480464 azaspiracid results in increased expression of MTHFD2 mRNA CTD PMID:28939011 azoxystrobin increases expression ISO RGD:1322701 6480464 azoxystrobin results in increased expression of MTHFD2 mRNA CTD PMID:33512557 benzalkonium chloride decreases expression ISO RGD:1322702 6480464 Benzalkonium Compounds results in decreased expression of MTHFD2 mRNA CTD PMID:31199489 benzo[a]pyrene decreases expression ISO RGD:1322701 6480464 Benzo(a)pyrene metabolite results in decreased expression of MTHFD2 mRNA, Benzo(a)pyrene results in decreased expression of MTHFD2 mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases methylation ISO RGD:1322701 6480464 Benzo(a)pyrene results in increased methylation of MTHFD2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1322701 6480464 Benzo(a)pyrene results in increased expression of MTHFD2 mRNA CTD PMID:26238291 , PMID:32234424 benzo[a]pyrene increases expression ISO RGD:1322702 6480464 Benzo(a)pyrene results in increased expression of MTHFD2 mRNA CTD PMID:21569818 , PMID:32417428 benzo[a]pyrene decreases expression ISO RGD:1322702 6480464 Benzo(a)pyrene results in decreased expression of MTHFD2 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1322701 6480464 7 more ... CTD PMID:26238291 bexarotene decreases expression ISO RGD:1322701 6480464 bexarotene results in decreased expression of MTHFD2 mRNA CTD PMID:17178900 bisphenol A increases expression ISO RGD:1322702 6480464 bisphenol A results in increased expression of MTHFD2 mRNA CTD PMID:26063408 bisphenol A decreases expression ISO RGD:1322702 6480464 bisphenol A results in decreased expression of MTHFD2 mRNA CTD PMID:32156529 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MTHFD2 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A affects expression ISO RGD:1322701 6480464 bisphenol A affects the expression of MTHFD2 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1322701 6480464 bisphenol A results in increased expression of MTHFD2 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MTHFD2 gene CTD PMID:28505145 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MTHFD2 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of MTHFD2 mRNA CTD PMID:26496021 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of MTHFD2 mRNA CTD PMID:32479839 bucladesine multiple interactions ISO RGD:1322701 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MTHFD2 mRNA CTD PMID:20823114 buta-1,3-diene increases expression ISO RGD:1322702 6480464 1, 3-butadiene results in increased expression of MTHFD2 mRNA CTD PMID:29038090 butan-1-ol multiple interactions ISO RGD:1322701 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MTHFD2 mRNA CTD PMID:29432896 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of MTHFD2 protein CTD PMID:21699967 carbamazepine affects expression ISO RGD:1322701 6480464 Carbamazepine affects the expression of MTHFD2 mRNA CTD PMID:24752500 , PMID:25979313 carbon nanotube increases expression ISO RGD:1322702 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:27106021 carbon nanotube multiple interactions ISO RGD:1322702 6480464 [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of MTHFD2 mRNA CTD PMID:25926378 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of MTHFD2 mRNA CTD PMID:18500788 chloropicrin increases expression ISO RGD:1322701 6480464 chloropicrin results in increased expression of MTHFD2 mRNA CTD PMID:26352163 chloroprene increases expression ISO RGD:1322702 6480464 Chloroprene results in increased expression of MTHFD2 mRNA CTD PMID:23125180 chlorpyrifos increases expression ISO RGD:1322702 6480464 Chlorpyrifos results in increased expression of MTHFD2 mRNA CTD PMID:34289071 choline multiple interactions ISO RGD:1322702 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MTHFD2 mRNA CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of MTHFD2 mRNA CTD PMID:22023808 cisplatin multiple interactions ISO RGD:1322701 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of MTHFD2 mRNA CTD PMID:30871063 cisplatin increases expression ISO RGD:1322701 6480464 Cisplatin results in increased expression of MTHFD2 mRNA CTD PMID:27594783 clobetasol increases expression ISO RGD:1322702 6480464 Clobetasol results in increased expression of MTHFD2 mRNA CTD PMID:27462272 copper atom multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of MTHFD2 mRNA CTD PMID:26033743 copper atom multiple interactions ISO RGD:1322701 6480464 [Chelating Agents binds to Copper] which results in increased expression of MTHFD2 mRNA CTD PMID:30911355 copper(0) multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of MTHFD2 mRNA CTD PMID:26033743 copper(0) multiple interactions ISO RGD:1322701 6480464 [Chelating Agents binds to Copper] which results in increased expression of MTHFD2 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RGD:1322701 6480464 Copper Sulfate results in increased expression of MTHFD2 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:1322701 6480464 coumarin results in increased phosphorylation of MTHFD2 protein CTD PMID:35688186 crocidolite asbestos affects expression ISO RGD:1322701 6480464 Asbestos, Crocidolite affects the expression of MTHFD2 mRNA CTD PMID:25757056 crocidolite asbestos increases expression ISO RGD:1322701 6480464 Asbestos, Crocidolite results in increased expression of MTHFD2 mRNA CTD PMID:29523930 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MTHFD2 mRNA CTD PMID:26577399 , PMID:27523638 cyclophosphamide decreases expression ISO RGD:1322701 6480464 Cyclophosphamide metabolite results in decreased expression of MTHFD2 mRNA CTD PMID:24356939 cyclosporin A affects expression ISO RGD:1322701 6480464 Cyclosporine affects the expression of MTHFD2 mRNA CTD PMID:25224403 cyclosporin A increases expression ISO RGD:1322701 6480464 Cyclosporine results in increased expression of MTHFD2 mRNA CTD PMID:20106945 more ... cyclosporin A increases expression ISO RGD:1322702 6480464 Cyclosporine results in increased expression of MTHFD2 mRNA CTD PMID:25224403 deguelin increases expression ISO RGD:1322701 6480464 deguelin results in increased expression of MTHFD2 mRNA CTD PMID:33512557 deoxynivalenol decreases expression ISO RGD:1322701 6480464 deoxynivalenol results in decreased expression of MTHFD2 mRNA CTD PMID:31863870 dexamethasone decreases expression ISO RGD:1322702 6480464 Dexamethasone results in decreased expression of MTHFD2 mRNA CTD PMID:22733784 diarsenic trioxide increases expression ISO RGD:1322701 6480464 Arsenic Trioxide results in increased expression of MTHFD2 mRNA CTD PMID:24356939 diclofenac affects expression ISO RGD:1322701 6480464 Diclofenac affects the expression of MTHFD2 mRNA CTD PMID:24752500 diclofenac decreases expression ISO RGD:1322702 6480464 Diclofenac results in decreased expression of MTHFD2 mRNA CTD PMID:35537566 dioxygen multiple interactions ISO RGD:1322702 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MTHFD2 mRNA, Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of MTHFD2 mRNA] CTD PMID:22629407 , PMID:30529165 dioxygen increases expression ISO RGD:1322702 6480464 Oxygen deficiency results in increased expression of MTHFD2 mRNA CTD PMID:22629407 disodium selenite increases expression ISO RGD:1322701 6480464 Sodium Selenite results in increased expression of MTHFD2 mRNA CTD PMID:24383545 dorsomorphin multiple interactions ISO RGD:1322701 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:1322701 6480464 Doxorubicin affects the expression of MTHFD2 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of MTHFD2 mRNA CTD PMID:29391264 entinostat multiple interactions ISO RGD:1322701 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTHFD2 mRNA CTD PMID:27188386 etoposide decreases expression ISO RGD:1322702 6480464 Etoposide results in decreased expression of MTHFD2 mRNA CTD PMID:25270620 fenpyroximate increases expression ISO RGD:1322701 6480464 fenpyroximate results in increased expression of MTHFD2 mRNA CTD PMID:33512557 fluoranthene multiple interactions ISO RGD:1322702 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of MTHFD2 mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:1322702 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MTHFD2 mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:1322702 6480464 Folic Acid results in decreased expression of MTHFD2 mRNA CTD PMID:25629700 gamma-hexachlorocyclohexane increases expression ISO RGD:1322701 6480464 Hexachlorocyclohexane results in increased expression of MTHFD2 mRNA CTD PMID:24356939 genistein decreases methylation EXP 6480464 Genistein results in decreased methylation of MTHFD2 gene CTD PMID:28505145 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MTHFD2 mRNA CTD PMID:33387578 glycine betaine decreases expression EXP 6480464 Betaine results in decreased expression of MTHFD2 mRNA CTD PMID:26391144 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of MTHFD2 mRNA CTD PMID:21396975 ivermectin decreases expression ISO RGD:1322701 6480464 Ivermectin results in decreased expression of MTHFD2 protein CTD PMID:32959892 L-ascorbic acid decreases expression ISO RGD:1322701 6480464 Ascorbic Acid results in decreased expression of MTHFD2 mRNA CTD PMID:19197388 L-methionine multiple interactions ISO RGD:1322702 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MTHFD2 mRNA CTD PMID:20938992 lamivudine multiple interactions ISO RGD:1322701 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of MTHFD2 mRNA CTD PMID:15784690 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of MTHFD2 mRNA CTD PMID:11578147 leflunomide increases expression ISO RGD:1322701 6480464 leflunomide results in increased expression of MTHFD2 mRNA CTD PMID:28988120 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of MTHFD2 mRNA CTD PMID:28801915 manganese(II) chloride increases methylation EXP 6480464 manganese chloride results in increased methylation of MTHFD2 gene CTD PMID:28801915 medroxyprogesterone acetate multiple interactions ISO RGD:1322701 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MTHFD2 mRNA CTD PMID:20823114 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of MTHFD2 mRNA CTD PMID:16507785 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of MTHFD2 mRNA CTD PMID:28619521 methylmercury chloride increases expression ISO RGD:1322701 6480464 methylmercuric chloride results in increased expression of MTHFD2 mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:1322701 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTHFD2 mRNA CTD PMID:27188386 miconazole increases expression ISO RGD:1322702 6480464 Miconazole results in increased expression of MTHFD2 mRNA CTD PMID:27462272 mitoxantrone affects response to substance ISO RGD:1322701 6480464 MTHFD2 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1322702 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MTHFD2 protein CTD PMID:26558463 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MTHFD2 mRNA CTD PMID:28801915 N-methyl-4-phenylpyridinium increases methylation EXP 6480464 1-Methyl-4-phenylpyridinium results in increased methylation of MTHFD2 gene CTD PMID:28801915 N-methyl-4-phenylpyridinium increases expression ISO RGD:1322701 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MTHFD2 mRNA CTD PMID:24810058 N-methyl-N-nitrosourea decreases expression EXP 6480464 Methylnitrosourea results in decreased expression of MTHFD2 mRNA CTD PMID:17412507 N-nitrosodiethylamine multiple interactions ISO RGD:1322702 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MTHFD2 mRNA CTD PMID:24535843 neomycin multiple interactions ISO RGD:1322702 6480464 Plant Oils inhibits the reaction [Neomycin results in decreased expression of MTHFD2 mRNA] CTD PMID:30626089 neomycin decreases expression ISO RGD:1322702 6480464 Neomycin results in decreased expression of MTHFD2 mRNA CTD PMID:30626089 nickel atom increases expression ISO RGD:1322701 6480464 Nickel results in increased expression of MTHFD2 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride increases expression ISO RGD:1322701 6480464 nickel chloride results in increased expression of MTHFD2 mRNA CTD PMID:17312168 ozone decreases expression ISO RGD:1322702 6480464 Ozone results in decreased expression of MTHFD2 mRNA CTD PMID:24336422 ozone multiple interactions ISO RGD:1322702 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MTHFD2 mRNA more ... CTD PMID:25658374 , PMID:34911549 paracetamol increases expression ISO RGD:1322701 6480464 Acetaminophen results in increased expression of MTHFD2 mRNA CTD PMID:21420995 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MTHFD2 mRNA CTD PMID:30723492 more ... paracetamol affects expression ISO RGD:1322701 6480464 Acetaminophen affects the expression of MTHFD2 mRNA CTD PMID:25704631 paracetamol affects expression ISO RGD:1322702 6480464 Acetaminophen affects the expression of MTHFD2 mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of MTHFD2 mRNA CTD PMID:32680482 pemetrexed increases response to substance ISO RGD:1322701 6480464 MTHFD2 protein results in increased susceptibility to Pemetrexed CTD PMID:24688052 perfluorooctanoic acid increases expression ISO RGD:1322701 6480464 perfluorooctanoic acid results in increased expression of MTHFD2 protein CTD PMID:26879310 phenobarbital multiple interactions ISO RGD:1322702 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MTHFD2 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MTHFD2 mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital increases expression ISO RGD:1322702 6480464 Phenobarbital results in increased expression of MTHFD2 mRNA CTD PMID:19482888 phosgene affects expression ISO RGD:1322702 6480464 Phosgene affects the expression of MTHFD2 mRNA CTD PMID:16300373 picoxystrobin increases expression ISO RGD:1322701 6480464 picoxystrobin results in increased expression of MTHFD2 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:1322701 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MTHFD2 mRNA CTD PMID:19710929 pirinixic acid multiple interactions ISO RGD:1322702 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MTHFD2 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1322702 6480464 pirinixic acid results in decreased expression of MTHFD2 mRNA CTD PMID:17426115 potassium bromate increases expression EXP 6480464 potassium bromate results in increased expression of MTHFD2 mRNA CTD PMID:23588252 potassium dichromate decreases expression ISO RGD:1322701 6480464 Potassium Dichromate results in decreased expression of MTHFD2 protein CTD PMID:23718831 progesterone increases expression ISO RGD:1322701 6480464 Progesterone results in increased expression of MTHFD2 mRNA CTD PMID:18037150 progesterone affects expression ISO RGD:1322702 6480464 Progesterone affects the expression of MTHFD2 mRNA CTD PMID:17251523 pyrimidifen increases expression ISO RGD:1322701 6480464 pyrimidifen results in increased expression of MTHFD2 mRNA CTD PMID:33512557 quinoline decreases expression ISO RGD:1322701 6480464 quinoline analog results in decreased expression of MTHFD2 protein CTD PMID:18645022 resveratrol increases expression ISO RGD:1322702 6480464 resveratrol results in increased expression of MTHFD2 mRNA CTD PMID:22610192 riddelliine decreases expression EXP 6480464 riddelliine results in decreased expression of MTHFD2 mRNA CTD PMID:18047727 rotenone increases expression ISO RGD:1322701 6480464 Rotenone results in increased expression of MTHFD2 mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1322701 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of MTHFD2 mRNA CTD PMID:33725128 SB 431542 multiple interactions ISO RGD:1322701 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1322701 6480464 Silicon Dioxide analog results in increased expression of MTHFD2 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1322702 6480464 Silicon Dioxide results in increased expression of MTHFD2 mRNA CTD PMID:23221170 , PMID:29341224 silver atom increases expression ISO RGD:1322701 6480464 Silver results in increased expression of MTHFD2 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1322701 6480464 Silver results in increased expression of MTHFD2 mRNA CTD PMID:26014281 sodium arsenite affects methylation ISO RGD:1322701 6480464 sodium arsenite affects the methylation of MTHFD2 gene CTD PMID:28589171 sodium arsenite multiple interactions ISO RGD:1322701 6480464 sodium arsenite promotes the reaction [MTHFD2 protein binds to CAPRIN1 protein] CTD PMID:33939924 sodium arsenite decreases methylation ISO RGD:1322701 6480464 sodium arsenite results in decreased methylation of MTHFD2 intron CTD PMID:32844245 sodium arsenite increases expression ISO RGD:1322701 6480464 sodium arsenite results in increased expression of MTHFD2 mRNA CTD PMID:29301061 , PMID:32844245 sodium arsenite increases expression ISO RGD:1322702 6480464 sodium arsenite results in increased expression of MTHFD2 mRNA CTD PMID:22700541 sulindac increases expression ISO RGD:1322701 6480464 Sulindac results in increased expression of MTHFD2 mRNA CTD PMID:11906190 sulindac sulfide increases expression ISO RGD:1322701 6480464 sulindac sulfide results in increased expression of MTHFD2 mRNA CTD PMID:12734198 sunitinib increases expression ISO RGD:1322701 6480464 Sunitinib results in increased expression of MTHFD2 mRNA CTD PMID:31533062 T-2 toxin decreases expression EXP 6480464 T-2 Toxin results in decreased expression of MTHFD2 mRNA CTD PMID:26141394 T-2 toxin decreases expression ISO RGD:1322701 6480464 T-2 Toxin results in decreased expression of MTHFD2 mRNA CTD PMID:31863870 tamoxifen affects expression ISO RGD:1322702 6480464 Tamoxifen affects the expression of MTHFD2 mRNA CTD PMID:17555576 tebufenpyrad increases expression ISO RGD:1322701 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of MTHFD2 mRNA CTD PMID:33512557 temozolomide increases expression ISO RGD:1322701 6480464 Temozolomide results in increased expression of MTHFD2 mRNA CTD PMID:31758290 testosterone affects expression ISO RGD:1322702 6480464 Testosterone affects the expression of MTHFD2 mRNA CTD PMID:20403060 testosterone multiple interactions ISO RGD:1322702 6480464 1 more ... CTD PMID:33848595 testosterone decreases expression ISO RGD:1322702 6480464 Testosterone deficiency results in decreased expression of MTHFD2 mRNA CTD PMID:33848595 tetrachloroethene increases expression ISO RGD:1322702 6480464 Tetrachloroethylene results in increased expression of MTHFD2 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO RGD:1322702 6480464 Carbon Tetrachloride results in increased expression of MTHFD2 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MTHFD2 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MTHFD2 mRNA CTD PMID:31150632 thapsigargin increases expression ISO RGD:1322701 6480464 Thapsigargin results in increased expression of MTHFD2 mRNA CTD PMID:22378314 , PMID:29453283 thifluzamide increases expression ISO RGD:1322701 6480464 thifluzamide results in increased expression of MTHFD2 mRNA CTD PMID:33512557 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MTHFD2 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1322702 6480464 titanium dioxide results in increased expression of MTHFD2 mRNA CTD PMID:23557971 , PMID:27760801 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of MTHFD2 mRNA CTD PMID:33387578 triclosan decreases expression ISO RGD:1322701 6480464 Triclosan results in decreased expression of MTHFD2 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:1322702 6480464 trimellitic anhydride results in increased expression of MTHFD2 mRNA CTD PMID:19042947 triptonide increases expression ISO RGD:1322702 6480464 triptonide results in increased expression of MTHFD2 mRNA CTD PMID:33045310 trovafloxacin decreases expression ISO RGD:1322702 6480464 trovafloxacin results in decreased expression of MTHFD2 mRNA CTD PMID:35537566 tunicamycin increases expression ISO RGD:1322701 6480464 Tunicamycin results in increased expression of MTHFD2 mRNA, Tunicamycin results in increased expression of MTHFD2 protein CTD PMID:22378314 more ... valproic acid affects expression ISO RGD:1322702 6480464 Valproic Acid affects the expression of MTHFD2 mRNA CTD PMID:17292431 , PMID:17963808 valproic acid decreases expression ISO RGD:1322701 6480464 Valproic Acid results in decreased expression of MTHFD2 mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO RGD:1322701 6480464 Valproic Acid affects the expression of MTHFD2 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MTHFD2 mRNA CTD PMID:23034163 zidovudine multiple interactions ISO RGD:1322701 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of MTHFD2 mRNA CTD PMID:15784690 zinc atom multiple interactions ISO RGD:1322701 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MTHFD2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1322701 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MTHFD2 mRNA CTD PMID:18593933
